Back to Search
Start Over
Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
- Source :
-
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 1999 Aug; Vol. 8 (4), pp. 261-7. - Publication Year :
- 1999
-
Abstract
- We studied the sequential changes in second messenger systems in the striatum and substantia nigra (SN) after 6-hydroxydopamine lesions of the medial forebrain bundle in rats. The animals were unilaterally lesioned in the medial forebrain bundle and the brains were analyzed at 1, 2, 4 and 8 weeks postlesion. [3H]Phorbol-12, 13-dibutyrate (PDBu), [3H]forskolin and [3H]rolipram were used to label protein kinase C (PKC), adenylyl cyclase and calcium/calmodulin-independent cyclic-AMP phosphodiesterase, respectively. The degeneration of nigrostriatal pathway produced a significant increase in [3H]PDBu binding in the ventromedial part of the ipsilateral striatum from 2 to 8 weeks postlesion. In the contralateral side, [3H]PDBu binding showed a transient increase in the SN only 4 weeks after lesioning. [3H]Forskolin binding showed a significant increase in the ipsilateral and contralateral striatum from 2 to 4 weeks postlesion. In the ipsilateral SN, a significant increase in [3H]forskolin binding was observed at 4 weeks after lesioning. However, no significant change in [3H]forskolin binding was observed in the contralateral SN during postlesion. On the other hand, [(3)H]rolipram binding showed no conspicuous alteration in the brain during postlesion. These results demonstrate that rats made hemiparkinsonism by unilateral 6-hydroxydopamine injection have a significant increase in [3H]PDBu and [3H]forskolin binding in the striatum and/or SN, whereas no significant change in [3H]rolipram binding is observed in these areas during postlesion. Our findings also suggest that the increase in [3H]forskolin binding is more pronounced than that in [3H]PDBu binding in the brain after unilateral 6-hydroxydopamine injection. Thus, our studies may provide valuable information concerning degeneration of the nigrostriatal pathway such as Parkinson's disease.
- Subjects :
- Animals
Antiparkinson Agents metabolism
Binding Sites
Brain enzymology
Carcinogens metabolism
Colforsin metabolism
Corpus Striatum metabolism
Corpus Striatum physiology
Male
Medial Forebrain Bundle metabolism
Phorbol 12,13-Dibutyrate metabolism
Pyrrolidinones metabolism
Rats
Rats, Wistar
Rolipram
Substantia Nigra metabolism
Substantia Nigra physiology
Tritium
Brain drug effects
Brain physiology
Medial Forebrain Bundle drug effects
Medial Forebrain Bundle physiology
Oxidopamine pharmacology
Second Messenger Systems drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 0928-0987
- Volume :
- 8
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
- Publication Type :
- Academic Journal
- Accession number :
- 10425376
- Full Text :
- https://doi.org/10.1016/s0928-0987(99)00017-2